Seizures have a meaningful genetic component, but calling them simply “hereditary” oversimplifies a layered picture. A large population-based study found that relatives of people with epilepsy face roughly a threefold increase in their own risk of developing the condition compared to the general population. That elevated risk is real, yet it still translates to a relatively modest absolute chance for any one family member. The genetics behind seizures range from rare single-gene disorders that follow clear inheritance patterns to constellations of common gene variants that each nudge risk by a tiny amount, and some seizure-causing genetic changes are not inherited at all.
How Much Does Family History Actually Raise the Risk?
The clearest answer to the heredity question comes from family studies. In a large population-based study, the cumulative incidence of epilepsy by age 40 among relatives of people with epilepsy was about 5%, with risk increased roughly 3.3-fold compared to what you would expect in the general population.1PubMed Central. Familial risk of epilepsy: a population-based study That sounds alarming at first, but consider the baseline: epilepsy affects about 1 to 2% of the general population over a lifetime. A threefold increase brings a relative’s risk to roughly 5%, which means about 95 out of 100 family members will never develop the condition. Family history matters, but it is far from destiny.
The type of epilepsy in the family also shapes the risk. Generalized epilepsies, where seizures involve both sides of the brain from the start, tend to have a stronger genetic component than focal epilepsies, where seizures begin in one brain region. If a close relative has generalized epilepsy, the risk to other family members is somewhat higher than if the relative has a focal form. But even within families carrying the same genetic change, seizure types and severity can vary widely from person to person.
Single-Gene Epilepsies
A small but important fraction of epilepsy cases trace back to a mutation in a single gene. These monogenic epilepsies often follow clear inheritance patterns and tend to be among the most severe forms. The best-studied example is Dravet syndrome, a childhood epilepsy caused by loss-of-function mutations in the SCN1A gene, which encodes a key sodium channel in the brain.2PubMed Central. Sodium channel SCN1A and epilepsy: mutations and mechanisms Mutations in SCN1A are dominantly inherited, meaning a single copy of the altered gene is enough to cause disease. In Dravet syndrome, the mutations usually arise fresh in the child rather than being passed down, but the milder GEFS+ syndrome (generalized epilepsy with febrile seizures plus) involves SCN1A missense mutations that do run through families.2PubMed Central. Sodium channel SCN1A and epilepsy: mutations and mechanisms
Dravet syndrome brings frequent seizures along with severe cognitive impairment, and animal research has revealed that the mechanism involves dysfunction of specific brain cells called interneurons, which normally keep neural activity in check.3PubMed Central. SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome It is a counterintuitive situation: the sodium channel mutation causes a loss of function, yet the result is excessive brain activity rather than reduced activity. The explanation is that the neurons most affected are the ones whose job is to suppress firing in surrounding cells.
Other single-gene epilepsies involve different ion channels and receptors. Mutations in potassium channel genes can also cause epilepsy, with both gain-of-function and loss-of-function changes producing seizures through different routes.4PubMed Central. Voltage-gated potassium channels and genetic epilepsy Sleep-related hypermotor epilepsy, for instance, has been linked to mutations in nicotinic acetylcholine receptor genes, with autosomal dominant inheritance documented across multiple generations in affected families.5PubMed. Two mutations in the nicotinic acetylcholine receptor subunit A4 (CHRNA4) in a family with autosomal dominant sleep-related hypermotor epilepsy
When Many Genes Share the Blame
Most epilepsy is not caused by a single dramatic mutation. Instead, the common forms of generalized epilepsy appear to result from the combined effects of many gene variants, each individually contributing a tiny nudge toward seizure risk. Researchers quantify this using polygenic risk scores, which add up the effects of hundreds or thousands of common variants identified through large genetic studies.6PubMed. Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy
A study comparing thousands of people with generalized epilepsy to tens of thousands of controls found that those with the highest polygenic risk scores were roughly four to five times more likely to have generalized epilepsy than those with average scores.7Brain. Polygenic burden in focal and generalized epilepsies That enrichment sounds substantial, but even the highest-scoring group captured only a small fraction of all cases. Current polygenic risk scores explain under 3% of the overall variation in who develops epilepsy and who does not. They are useful research tools, but they are nowhere near predictive enough to tell any one person whether seizures lie in their future.
Polygenic risk scores also distinguish between epilepsy subtypes. The same study found that people with generalized epilepsy had significantly higher generalized-epilepsy risk scores than people with focal epilepsy, supporting the long-held clinical observation that generalized forms carry a stronger inherited component.7Brain. Polygenic burden in focal and generalized epilepsies
Copy Number Variations
Beyond single-letter changes in DNA and the subtle effects of common variants, larger structural rearrangements of the genome also contribute to epilepsy risk. These copy number variations, or deletions and duplications of sizable chunks of DNA, are found at higher rates in people with epilepsy than in the general population. In one clinical cohort, copy number changes explained the epilepsy in about 5% of patients.8PubMed Central. Copy number variation plays an important role in clinical epilepsy
Certain chromosomal regions are repeat offenders. Deletions at 15q13.3, 16p13.11, and 15q11.2 are significantly enriched in people with epilepsy, together accounting for about 3% of cases in one large study.9PLoS Genetics. Genome-Wide Copy Number Variation in Epilepsy: Novel Susceptibility Loci in Idiopathic Generalized and Focal Epilepsies A broader burden analysis found that people with genetic generalized epilepsy carry large, rare deletions about twice as often as controls, and that these deletions disproportionately affect genes involved in brain development.10PubMed Central. Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies Some of these deletions can be inherited from a parent who carries the same change but has no seizures, illustrating how the same genetic rearrangement can have different effects in different people.
Genetic but Not Inherited
An important distinction that often gets lost in the “is it hereditary” conversation: some seizure-causing genetic changes happen after conception and exist only in certain cells. These somatic mutations arise during fetal brain development and can produce structural abnormalities that cause severe, drug-resistant epilepsy without any family history whatsoever.
The clearest example is focal cortical dysplasia type II, a brain malformation that is one of the most common causes of seizures that do not respond to medication. Researchers using deep sequencing of brain tissue from people with this condition found somatic mutations in the MTOR gene in about 16% of cases studied.11PubMed. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy These mutations are not present in blood and cannot be detected by standard genetic tests. They exist only in the affected brain tissue, making them invisible to the kind of testing a doctor would order based on a blood draw. In at least some cases, the mutations can be distributed across both brain hemispheres, complicating surgical approaches that aim to remove the affected area.12PubMed Central. Is Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?
Because somatic mutations cannot be passed to children, this category of genetic epilepsy carries no increased recurrence risk for future offspring. It is genetic in origin but not hereditary in the way most people mean when they ask the question.
Febrile Seizures and GEFS+
Febrile seizures, the convulsions that happen in young children during high fevers, are the most common seizure type in childhood and run strongly in families. Most febrile seizures are benign and children outgrow them. But some families show a pattern called GEFS+, where febrile seizures persist beyond the typical age window or evolve into afebrile seizures.13PubMed. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes Within these families, one member might have only childhood febrile seizures while another develops lifelong epilepsy, and the range of severity is broad even among people carrying the same gene variant.14PubMed. Generalized epilepsy with febrile seizures plus: further heterogeneity in a large family
GEFS+ highlights a recurring theme in epilepsy genetics: the same mutation can produce very different outcomes in different family members. This variability is partly why genetic counseling in epilepsy is more nuanced than a simple “you have the gene, you will get seizures” conversation. Modifier genes, environmental exposures, and chance all influence whether a genetic predisposition becomes a clinical problem.
Can Your Genes Make You More Vulnerable to Seizures After a Brain Injury?
Seizures caused by head trauma, stroke, or brain infections are typically thought of as acquired rather than genetic. But emerging research suggests your genetic background can influence how likely you are to develop epilepsy after one of these insults. In selectively bred rats, animals genetically prone to seizures showed a dramatically worse response to experimental brain injury, with a 100% seizure rate and death within 24 hours, while seizure-resistant animals had no acute seizures and recovered faster.15PubMed. Inherent Susceptibility to Acquired Epilepsy in Selectively Bred Rats Influences the Acute Response to Traumatic Brain Injury
In humans, a systematic review identified several gene variants that appear to increase the likelihood of developing post-traumatic epilepsy. Variants in the interleukin-1β gene and the adenosine A1 receptor gene showed the most promising associations, with carriers of certain variants developing seizures after brain injury at significantly higher rates.16PubMed. Genetic biomarkers of posttraumatic epilepsy: A systematic review This research is still early, but it suggests that the boundary between “genetic” and “acquired” epilepsy may be blurrier than the traditional categories imply.
Mitochondrial Inheritance Adds Another Layer
Not all genetic material sits on the 23 pairs of chromosomes you inherit from your parents. Mitochondria, the energy-producing structures inside cells, carry their own small genome, and mutations in mitochondrial DNA are a recognized cause of epilepsy. Mitochondrial diseases are collectively more common than many people realize, with a combined prevalence of roughly 1 in 4,300 people, and the POLG gene and mutations in mitochondrial DNA itself are the major genetic culprits behind mitochondrial epilepsy.17PubMed Central. Mitochondrial Epilepsy, a Challenge for Neurologists
Mitochondrial DNA is inherited exclusively from the mother, so mitochondrial epilepsy follows a maternal inheritance pattern. A father with a mitochondrial DNA mutation will not pass it to any of his children. A mother carrying the mutation will pass it to all of her children, though the severity can vary enormously depending on what proportion of her mitochondria carry the mutation. Nuclear genes like POLG follow standard inheritance patterns and can come from either parent.
What Genetic Testing Can and Cannot Tell You
If epilepsy runs in your family, or if you or your child has seizures that started early and resist treatment, genetic testing is increasingly part of the clinical workup. A meta-analysis of diagnostic genetic testing in epilepsy found that whole-exome sequencing identified a genetic cause in roughly 45% of cases tested, epilepsy gene panels found one in about 23% of cases, and chromosomal microarray analysis in about 8%.18PubMed Central. Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study These numbers apply mostly to people selected for testing because their epilepsy was suspected to have a genetic basis. If you tested everyone with epilepsy, the yield would be lower.
When a pathogenic variant is found, it opens the door to genetic counseling for the family, including discussions about recurrence risk for siblings and future children, as well as reproductive options like prenatal or pre-implantation genetic testing.19PubMed. Genetic Testing in Pediatric Epilepsy A negative genetic test, however, does not rule out a genetic contribution. Many epilepsy-related genes have yet to be discovered, and the polygenic contributions of common variants are not captured by standard clinical testing.
How Genetics Is Changing Epilepsy Treatment
Identifying the specific genetic cause of epilepsy is not just an academic exercise. It can directly influence which medications work and which ones to avoid. The concept of precision medicine in epilepsy aims to match treatment to the underlying genetic defect, and the field is well positioned for this approach because of the growing number of known epilepsy genes and the availability of good laboratory models to test treatments.20PubMed Central. A roadmap for precision medicine in the epilepsies Knowing the genetic cause can explain why a person responds well to certain drugs and poorly to others, and in some cases it points toward a targeted therapy that addresses the root problem rather than broadly suppressing brain activity.21Neurotherapeutics. Current Perspectives From Genetic Testing to Precision Medicine in Epilepsy
For example, people with Dravet syndrome caused by SCN1A loss-of-function mutations can be harmed by sodium channel-blocking drugs like carbamazepine, which would be a standard first-line option for other types of epilepsy. Without knowing the genetic diagnosis, a doctor might reasonably prescribe a drug that makes the situation worse. Precision medicine in epilepsy is still developing, but the genetic basis of many epilepsies is increasingly understood, giving rise to the possibility of treatments tailored to specific genetic causes.22PubMed Central. Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress
Your Genes Also Affect Drug Side Effects
Separate from whether genetics cause your seizures, your genetic makeup influences how your body handles anti-seizure medications. This field, pharmacogenomics, has already produced findings that affect real clinical decisions. Genetic variations in the CYP2C9 enzyme affect how quickly the body breaks down phenytoin, a widely used seizure drug, and people with certain CYP2C9 variants are at higher risk of toxicity at standard doses.23PubMed Central. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update
More dramatically, the HLA-B*15:02 variant, found primarily in people of Southeast Asian descent, is associated with a heightened risk of Stevens-Johnson syndrome and toxic epidermal necrolysis, severe and sometimes fatal skin reactions, in response to certain anti-seizure drugs including phenytoin and carbamazepine.23PubMed Central. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update Screening for this variant before prescribing these drugs is now recommended in clinical guidelines and has been incorporated into drug labeling.24PubMed Central. Pharmacogenetics of antiepileptic drugs: A brief review This is one of the clearest success stories of genetics influencing everyday epilepsy care.
Epigenetics and the Role of Environment
Genes do not operate in a vacuum. Epigenetic changes, modifications to how genes are read without altering the DNA sequence itself, play a growing role in our understanding of seizure disorders. Processes like DNA methylation, histone modification, and the activity of non-coding RNA molecules can dial gene expression up or down in ways that influence brain excitability.25PubMed Central. Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies These epigenetic mechanisms interact with the same signaling pathways disrupted in genetic epilepsies and may help explain why two people with the same DNA variant can have such different clinical outcomes.26PubMed. Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy
Non-coding RNAs, stretches of genetic material that do not produce proteins but regulate other genes, are dysregulated in both human epilepsy patients and animal models of the condition.27PubMed Central. Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy Researchers are exploring whether these molecules could serve as biomarkers for epilepsy progression or as targets for new therapies.28PubMed Central. Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy Environmental factors like sleep deprivation, stress, and seizures themselves can trigger epigenetic changes, creating a dynamic interplay between genes and experience that shapes seizure susceptibility over a person’s lifetime.
The Emotional Weight of Genetic Risk
Learning that epilepsy has a genetic component in your family carries psychological consequences that go beyond the medical facts. Among people with epilepsy, those who perceived that genetics played a meaningful role in causing their condition reported higher levels of felt stigma compared to those who attributed their epilepsy to other causes.29PubMed Central. Genetic Causal Attribution of Epilepsy and its Implications for Felt Stigma Perhaps counterintuitively, this effect was specific to people who had epilepsy themselves. Their relatives without epilepsy did not show increased stigma from the genetic framing.
However, relatives carry their own burdens. Among biological family members without epilepsy, the prevalence of depression increased as they perceived a higher chance of carrying an epilepsy-related mutation themselves, and this was not simply because they feared developing seizures in the future.30PubMed Central. Depression and genetic causal attribution of epilepsy in multiplex epilepsy families Family members, particularly siblings and children of people with epilepsy, also reported notable rates of stigma and depressive symptoms, with rates of about 10% and 11% respectively.31PubMed. Factors associated with stigma and depressive symptoms in family members of patients with epilepsy These findings suggest that conversations about genetic risk in epilepsy need to address psychological well-being alongside medical facts, especially when working with families where multiple members are affected.